Definitions and reporting of hypoglycaemia in trials of long-acting insulin analogues in people with type 1 diabetes mellitus

1) To assess the various definitions and time points of measurement of hypoglycaemic events in randomised controlled trials (RCT) on long-acting insulin analogues in people with type 1 diabetes mellitus.

2) To assess if the risk estimates of various hypoglycaemic events are identical, and consistently reported in published and unpublished sources.

This is a protocol.

Share/Save